MDVN 111.22 Medivation Inc $MDVN Hit a 52 week high of

New Post Public Reply Private Reply Replies (0) Message Board

Nov 10, 2014 at 12:11 PM

MDVN 111.22 Medivation Inc $MDVN Hit a 52 week high of 113.48 Currently at 111.22 -1.55 -1.37% With a day low of 111.37 and a total volume of 72,503.

MDVN Medivation Inc Recent Headline News

Uptrend Call Working As Medivation Stock Rises 15.2% (MDVN)
Comtex SmarTrend(R) - 1 hr 32 mins ago
SmarTrend identified an Uptrend for Medivation (NASDAQ:MDVN) on October 21st, 2014 at $96.87. In approximately 3 weeks, Medivation has returned 15.20% as of today's recent price of $111.60.
MDVN: 110.35 (-2.42)

VYCOR: "On the Cusp of the Next Big Healthcare Trend"
ACCESSWIRE - 2 hrs 47 mins ago
Vycor: "On the Cusp of the Next Big Healthcare Trend"
MDVN: 110.35 (-2.42), ABMD: 32.58 (+0.45), JNJ: 108.48 (+0.28), AMGN: 162.54 (+2.29), EXAS: 22.59 (-0.23), ARAY: 6.85 (unch), HOLX: 26.45 (+0.24), PBYI: 240.65 (+3.76)

The Next Chapter in Dendron's Troubled History: Chapter 11 Bankruptcy
at The Street - Mon Nov 10, 6:12AM CST
A Dendreon agreement calls for a financial restructuring of the company in which the bondholders will receive equity for the debt owed, potentially wiping out current equity shareholders.
MDVN: 110.35 (-2.42), JNJ: 108.48 (+0.28), DNDN: 0.23 (-0.71)

5 Prescription Drugs Selling Like Hot Cakes
Todd Campbell, The Motley Fool - Motley Fool - Sun Nov 09, 9:01AM CST
Considering that 90% of prescription drugs being developed by biotechnology companies will fail during clinical trials, it can be tough to know which biotech stocks to seize upon and which stocks to shun. Instead of focusing on unproven...
MDVN: 110.35 (-2.42), JNJ: 108.48 (+0.28), BIIB: 324.99 (+4.24), PTLA: 27.25 (-0.14), GILD: 108.25 (+1.80), CELG: 107.80 (+1.35)

Look for Shares of Medivation to Potentially Pullback after Yesterday's 7.45% Rise
Comtex SmarTrend(R) - Fri Nov 07, 3:46PM CST
Medivation (NASDAQ:MDVN) traded in a range yesterday that spanned from a low of $102.04 to a high of $113.61. Yesterday, the shares gained 7.5%, which took the trading range above the 3-day high of $106.79 on volume of 3.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
MDVN: 110.35 (-2.42)

Clarification: Earns-Medivation story
AP - Fri Nov 07, 11:53AM CST
SAN FRANCISCO (AP) — In a story Nov. 7, The Associated Press reported that Medivation Inc. missed third-quarter earnings and revenue expectations based on the average of seven forecasts from Zacks Investment Research. The story was later updated to reflect that the company beat expectations based on the average of 18 estimates from FactSet.
MDVN: 110.35 (-2.42)

Medivation Q3 Earnings, Revenues Lag Estimates - Analyst Blog
Arpita Dutt - Zacks Investment Research - Fri Nov 07, 11:08AM CST
Medivation's (MDVN) Xtandi should see strong uptake in the chemo-naive patient population from the fourth quarter.
CYTK: 4.17 (+0.07), MDVN: 110.35 (-2.42), BIIB: 324.99 (+4.24)

Medivation Hits High After Q3 Earnings Beat
at Investor's Business Daily - Fri Nov 07, 10:15AM CST
Biotech Medivation (MDVN) jumped to a new high in the stock market today after its Q3 results beat estimates late Thursday on strong sales of cancer drug Xtandi. Medivation's earnings totaled 96 cents a share, reversing a year-earlier loss and...
MDVN: 110.35 (-2.42), AOL: 44.22 (+1.54), AZN: 73.26 (+0.38)

Medivation Reports Third Quarter Financial Results and Provides Corporate Update
Marketwired - Thu Nov 06, 3:13PM CST
Medivation, Inc. (NASDAQ: MDVN) today reported its financial results for the third quarter ended September 30, 2014. U.S. net sales of XTANDI(R) (enzalutamide) capsules for the quarter, as reported by Astellas Pharma Inc., were $181.4 million (+67% vs. prior year). Ex-U.S. net sales of XTANDI for the quarter, as reported by Astellas, were $119.6 million.
MDVN: 110.35 (-2.42)

Medivation Announces Participation at Upcoming Investor Conference
Marketwired - Wed Nov 05, 3:11PM CST
Medivation, Inc. (NASDAQ: MDVN) today announced that it will present at the following conference:
MDVN: 110.26 (-2.51)

3 Biotech Stocks for Earnings Beats this Season - Earnings ESP
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 12:38PM CST
Many biotech stocks are exploring their own ways to emerge as winners.
MDVN: 110.26 (-2.51), ENDP: 69.36 (+0.40), AUXL: 32.91 (+0.16), SHPG: 201.46 (+2.88), DNDN: 0.23 (-0.71), SNSS: 1.60 (-0.03), ABBV: 63.79 (+2.29), SNY: 46.32 (+0.63), MNKD: 5.81 (+0.03), XOMA: 3.84 (+0.03)

Strong Prostate Cancer Drug Sales Will Help Medivation Expand Pipeline
at The Street - Wed Nov 05, 7:00AM CST
The diversification away from Xtandi has only just begun.
MDVN: 110.26 (-2.51)

Will Perrigo (PRGO) Disappoint This Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 3:45PM CST
Perrigo (PRGO), which is scheduled to report first-quarter fiscal 2015 results on Nov 6, had delivered a positive earnings surprise of 12.26%.
MDVN: 110.31 (-2.46), ACT: 247.52 (+1.61), PRGO: 156.39 (+0.62), ALNY: 98.53 (+2.69)

Will Humana (HUM) Miss on Earnings Estimates this Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 2:50PM CST
Humana Inc. (HUM) is set to report third-quarter 2014 earnings results on Nov 7, 2014.
MACK: 8.65 (-0.05), MDVN: 110.31 (-2.46), ALNY: 98.38 (+2.54), HUM: 132.82 (+2.24)

Geron Q3 Loss Wider, Shares Up on Removal of Clinical Hold - Analyst Blog
Arpita Dutt - Zacks Investment Research - Tue Nov 04, 8:00AM CST
Geron's (GERN) third quarter results were totally overshadowed by the removal of the full clinical hold on the IND application for imetelstat.
CYTK: 4.17 (+0.07), MDVN: 110.31 (-2.46), BIIB: 324.99 (+4.24), GERN: 2.25 (-0.08)

Geron Corporation (GERN) Looks Strong: Stock Up 25.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 7:44AM CST
Geron Corporation (GERN) was a big mover last session, as the company saw its shares surge nearly 26% on the day
MDVN: 110.31 (-2.46), ONCY: 0.81 (+0.11), GERN: 2.25 (-0.08), ILMN: 189.47 (+3.12)

Is Hospira (HSP) Poised to Beat Q3 Earnings Estimates? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 4:00PM CST
Hospira (HSP), which is scheduled to report third-quarter 2014 results on Nov 6, had posted a positive earnings surprise of 28.57%.
MDVN: 110.31 (-2.46), ACT: 247.52 (+1.61), ALNY: 98.38 (+2.54), HSP: 56.29 (-0.03)

Will DaVita Healthcare (DVA) Disappoint Earnings in Q3? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 1:40PM CST
DaVita Healthcare Partners, Inc. (DVA) is set to report third-quarter 2014 earnings on Nov 6, 2014.
MDVN: 110.31 (-2.46), AMSG: 51.29 (-0.21), DVA: 74.51 (+0.02), ALNY: 98.38 (+2.54)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tolnai Joins UPCEA Leaders Pioneering Credential Innovations

The Future of Education Shaped Today There's a profound shift happening in higher education, and it's not the usual undergrad grind most folks think of. Cate Tolnai, stepping into her role at the University of Phoenix, is in the thick of it. She's set to join the UPCEA Council for Credential Innovation's leadership team, and that isn't some fluff title. Her appointment...

Mega Matrix Shares Consolidation Ahead: What It Means

Quick and Unexpected Moves at Mega Matrix Just when you thought things couldn't get more complicated in the world of Mega Matrix Inc. (NYSE: MPU), they pull a rabbit out of the hat at their Extraordinary General Meeting on September 1st. Held at their office in Singapore, shareholders green-lighted some heavy-hitting changes like a share consolidation—twenty into one...

York Urged to Retire Research Macaques After Probe

Undercover Investigation Shakes Up York University If you thought the world of research was all about sterile labs and the pursuit of knowledge, think again. The Jane Goodall Institute (JGI), famed for championing animal welfare, has urged York University to let go of nine long-suffering rhesus macaques. Turns out, these macaques weren't exactly living their best lives....

LITEON Bets Big on Liquid Cooling with DCX Stake

Liquid Cooling: The AI Data Center Game Changer Alright, here's a twist in the tech saga that even a crusty old trader like me finds intriguing. LITEON (2301.TW) has made a bold move investing in DCX Liquid Cooling Systems with a $176 million deal for 25% equity. We're talking about liquid cooling here—it's the magic ingredient when your AI and HPC data centers start...

Costa Rica's Summit Draws Global Investors, Buyers

Costa Rica's Big Stage for Business and Opportunity You might look at Costa Rica and think of lush rainforests and coffee beans, but right now, it's a hub bustling with suits, spreadsheets, and strategic meetings. Over three days, the Costa Rica Trade & Investment Summit (CRTIS) gathered nearly half a thousand buyers and investors all under one roof in San José. Local...

EzCheckPrinting Boosts Remote Check Solutions Cost-Effectively

Navigating the Check Printing Landscape Let's dive right into the changing realities of the workspace. With remote work becoming the new standard, small businesses are juggling tighter budgets while trying to maintain smooth financial operations. It's a hard game, but here is where Halfpricesoft.com rolls out their newly upgraded multi-user ezCheckPrinting software,...

Supercharged Entertainment's Big Bet in Ohio's Polaris

Fasten your seatbelts, folks—because there's a tinge of burnt rubber in the air at Columbus's Polaris Center. Supercharged Entertainment, the big guns in indoor karting, just kicked off construction at their brand-new venue, and it’s looking like a gearhead's paradise. A sprawling 16-acre parcel is set to become a haven for adrenaline junkies come Summer 2027. A Bold...

Navimow's H5 Pro Mower Marries Tech with Nature Care

Garden Tech Reinvented: Enter the H5 Pro Mower Welcome to the 21st-century garden, where robotic ingenuity meets a genuine regard for nature. Folks, the Navimow H5 Pro just rolled onto the scene and it’s tearing up the old playbook of garden maintenance. It’s like blending Silicon Valley tech with Jane Goodall’s wildlife sensibilities. We're talking zero-edge...

Associated Banc-Corp Preps for Barclays Financial Conference

Associated Banc-Corp Heads to New York for Key Financial Services Conference Wake up and smell the coffee, folks—Associated Banc-Corp (NYSE: ASB) is set to make waves at the 24th Annual Barclays Global Financial Services Conference in New York. From September 14th to 16th, seasoned execs from ASB plan to rub elbows with the industry's heavy hitters, presenting their...

Art Ave Spurs Rebirth in Downtown DC: A Template for Revival

Turning Streets into Art Galleries No one would have believed a stretch of DC's bureaucratic offices was about to morph into a vibrant destination worthy of major art aficionados. But here we are, tipping our hats to the Golden Triangle Business Improvement District (BID), who just snagged the IDA Downtown Achievement Award of Excellence for their Art Ave project. Not...